$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis 원문보기

Psychiatry investigation, v.14 no.2, 2017년, pp.205 - 215  

Seo, Eun Hyun (Premedical Science, College of Medicine, Chosun University, Gwangju, Republic of Korea.) ,  Park, Woon Yeong (National Research Center for Dementia, Chosun University, Gwangju, Republic of Korea.) ,  Choo, IL Han (National Research Center for Dementia, Chosun University, Gwangju, Republic of Korea.)

Abstract AI-Helper 아이콘AI-Helper

ObjectiveThe aim of this study was to explore the prognostic values of biomarkers of neurodegeneration as measured by magnetic resonance imaging (MRI) and amyloid burden as measured by amyloid positron emission tomography (PET) in predicting conversion to Alzheimer's disease (AD) in patients with mi...

주제어

참고문헌 (51)

  1. 1 Albert MS DeKosky ST Dickson D Dubois B Feldman HH Fox NC The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 270 279 21514249 

  2. 2 Dubois B Feldman HH Jacova C Cummings JL Dekosky ST Barberger-Gateau P Revising the definition of Alzheimer’s disease: a new lexicon Lancet Neurol 2010 9 1118 1127 20934914 

  3. 3 Prestia A Caroli A Wade SK van der Flier WM Ossenkoppele R Van Berckel B Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics Alzheimers Dement 2015 11 1191 1201 25646957 

  4. 4 Petersen RC Smith GE Waring SC Ivnik RJ Tangalos EG Kokmen E Mild cognitive impairment: clinical characterization and outcome Arch Neurol 1999 56 303 308 10190820 

  5. 5 Winblad B Palmer K Kivipelto M Jelic V Fratiglioni L Wahlund LO Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment J Intern Med 2004 256 240 246 15324367 

  6. 6 McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 1984 34 939 944 6610841 

  7. 7 American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV (4th Ed.) Washington, DC American Psychiatric Association 1994 

  8. 8 Whiting PF Rutjes AW Westwood ME Mallett S Deeks JJ Reitsma JB QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 2011 155 529 536 22007046 

  9. 9 Higgins JP Thompson SG Quantifying heterogeneity in a meta-analysis Stat Med 2002 21 1539 1558 12111919 

  10. 10 deToledo-Morrell L Stoub TR Bulgakova M Wilson RS Bennett DA Leurgans S MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD Neurobiol Aging 2004 25 1197 1203 15312965 

  11. 11 Jack CR Jr Shiung MM Weigand SD O'Brien PC Gunter JL Boeve BF Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI Neurology 2005 65 1227 1231 16247049 

  12. 12 Wang PN Lirng JF Lin KN Chang FC Liu HC Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan Neurobiol Aging 2006 27 1797 1806 16321457 

  13. 13 Caroli A Testa C Geroldi C Nobili F Barnden LR Guerra UP Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment J Neurol 2007 254 1698 1707 17990057 

  14. 14 Desikan RS Fischl B Cabral HJ Kemper TL Guttmann CR Blacker D MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD Neurology 2008 71 819 825 18672473 

  15. 15 Eckerstrom C Olsson E Borga M Ekholm S Ribbelin S Rolstad S Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Goteborg MCI study J Neurol Sci 2008 272 48 59 18571674 

  16. 16 Bakkour A Morris JC Dickerson BC The cortical signature of prodromal AD: regional thinning predicts mild AD dementia Neurology 2009 72 1048 1055 19109536 

  17. 17 Waragai M Okamura N Furukawa K Tashiro M Furumoto S Funaki Y Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease J Neurol Sci 2009 285 100 108 19552926 

  18. 18 Fritzsche KH Stieltjes B Schlindwein S van Bruggen T Essig M Meinzer HP Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment Int J Comput Assist Radiol Surg 2010 5 623 632 20440655 

  19. 19 Galluzzi S Geroldi C Ghidoni R Paghera B Amicucci G Bonetti M The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment J Neurol 2010 257 2004 2014 20632026 

  20. 20 Plant C Teipel SJ Oswald A Bohm C Meindl T Mourao-Miranda J Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease Neuroimage 2010 50 162 174 19961938 

  21. 21 Scola E Bozzali M Agosta F Magnani G Franceschi M Sormani MP A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up J Neurol Neurosurg Psychiatry 2010 81 798 805 20392973 

  22. 22 Moretti DV Frisoni GB Fracassi C Pievani M Geroldi C Binetti G MCI patients' EEGs show group differences between those who progress and those who do not progress to AD Neurobiol Aging 2011 32 563 571 20022139 

  23. 23 Westman E Cavallin L Muehlboeck JS Zhang Y Mecocci P Vellas B Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease PLoS One 2011 6 e22506 21811624 

  24. 24 Devanand DP Bansal R Liu J Hao X Pradhaban G Peterson BS MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease Neuroimage 2012 60 1622 1629 22289801 

  25. 25 Munoz-Ruiz MA Hartikainen P Koikkalainen J Wolz R Julkunen V Niskanen E Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometry PLoS One 2012 7 e52531 23285078 

  26. 26 Thurfjell L Lotjonen J Lundqvist R Koikkalainen J Soininen H Waldemar G Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment Neurodegener Dis 2012 10 246 249 22301718 

  27. 27 Bruck A Virta JR Koivunen J Koikkalainen J Scheinin NM Helenius H [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment Eur J Nucl Med Mol Imaging 2013 40 1567 1572 23801168 

  28. 28 Douaud G Menke RA Gass A Monsch AU Rao A Whitcher B Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease J Neurosci 2013 33 2147 2155 23365250 

  29. 29 Rowe CC Bourgeat P Ellis KA Brown B Lim YY Mulligan R Predicting Alzheimer disease with beta-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing Ann Neurol 2013 74 905 913 24448836 

  30. 30 Selnes P Aarsland D Bjornerud A Gjerstad L Wallin A Hessen E Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment J Alzheimers Dis 2013 33 723 736 23186987 

  31. 31 Vos SJ van Rossum IA Verhey F Knol DL Soininen H Wahlund LO Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI Neurology 2013 80 1124 1132 23446677 

  32. 32 Ong KT Villemagne VL Bahar-Fuchs A Lamb F Langdon N Catafau AM Abeta imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study J Neurol Neurosurg Psychiatry 2015 86 431 436 24970906 

  33. 33 Varon D Barker W Loewenstein D Greig M Bohorquez A Santos I Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome Int J Geriatr Psychiatry 2015 30 192 200 24816477 

  34. 34 Wolk DA Price JC Saxton JA Snitz BE James JA Lopez OL Amyloid imaging in mild cognitive impairment subtypes Ann Neurol 2009 65 557 568 19475670 

  35. 35 Shao H Okamura N Sugi K Furumoto S Furukawa K Tashiro M Voxel-based analysis of amyloid positron emission tomography probe [C]BF-227 uptake in mild cognitive impairment and alzheimer's disease Dement Geriatr Cogn Disord 2010 30 101 111 20733303 

  36. 36 Doraiswamy PM Sperling RA Coleman RE Johnson KA Reiman EM Davis MD Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study Neurology 2012 79 1636 1644 22786606 

  37. 37 Hatashita S Yamasaki H Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction PLoS One 2013 8 e66877 23799136 

  38. 38 Nordberg A Carter SF Rinne J Drzezga A Brooks DJ Vandenberghe R A European multicentre PET study of fibrillar amyloid in Alzheimer's disease Eur J Nucl Med Mol Imaging 2013 40 104 114 22961445 

  39. 39 Trzepacz PT Yu P Sun J Schuh K Case M Witte MM Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia Neurobiol Aging 2014 35 143 151 23954175 

  40. 40 Yuan Y Gu ZX Wei WS Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis AJNR Am J Neuroradiol 2009 30 404 410 19001534 

  41. 41 Zhang S Han D Tan X Feng J Guo Y Ding Y Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment Int J Clin Pract 2012 66 185 198 22257044 

  42. 42 Chen X Li M Wang S Zhu H Xiong Y Liu X Pittsburgh compound B retention and progression of cognitive status--a meta-analysis Eur J Neurol 2014 21 1060 1067 24612390 

  43. 43 Prestia A Caroli A van der Flier WM Ossenkoppele R Van Berckel B Barkhof F Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease Neurology 2013 80 1048 1056 23390179 

  44. 44 Dubois B Feldman HH Jacova C Dekosky ST Barberger-Gateau P Cummings J Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 2007 6 734 746 17616482 

  45. 45 Whitwell JL Shiung MM Przybelski SA Weigand SD Knopman DS Boeve BF MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment Neurology 2008 70 512 520 17898323 

  46. 46 Reisberg B Ferris SH de Leon MJ Crook T The Global Deterioration Scale for assessment of primary degenerative dementia Am J Psychiatry 1982 139 1136 1139 7114305 

  47. 47 Petersen RC Mild cognitive impairment or questionable dementia? Arch Neurol 2000 57 643 614 10815128 

  48. 48 Levy R Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization Int Psychogeriatr 1994 6 63 68 8054494 

  49. 49 Petersen RC Doody R Kurz A Mohs RC Morris JC Rabins PV Current concepts in mild cognitive impairment Arch Neurol 2001 58 1985 1992 11735772 

  50. 50 Dubois B Feldman HH Jacova C Dekosky ST Barberger-Gateau P Cummings J Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 2007 6 734 746 17616482 

  51. 51 Petersen RC Mild cognitive impairment as a diagnostic entity J Intern Med 2004 256 183 194 15324362 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로